Multidrug-resistant tuberculosis in COVID-19: Double trouble

Area of Science:

• Infectious Diseases
• Public Health
• Hepatology

Background:

• India faces a high global burden of multidrug-resistant tuberculosis (MDR TB).
• The COVID-19 pandemic significantly impacted global healthcare systems and patient access to essential services.
• Chronic diseases like hepatitis B require consistent medical management and medication adherence.

Observation:

• The COVID-19 pandemic and associated lockdowns created substantial barriers to healthcare delivery and medication distribution in India.
• Patients with tuberculosis (TB) already face significant challenges due to social stigma, leading to mental distress and treatment non-compliance.
• Access to medical care for patients with pre-existing conditions became more difficult during the COVID-19 lockdown.

Findings:

• This case study examines the complex interplay between MDR TB, chronic hepatitis B, and the COVID-19 pandemic in a single patient.
• Management of MDR TB and hepatitis B was complicated by pandemic-related disruptions and patient-related fears.
• The study highlights the compounded difficulties faced by vulnerable patient populations during public health crises.

Implications:

• The findings underscore the need for resilient healthcare systems capable of managing chronic diseases during pandemics.
• Addressing the dual burden of infectious diseases and the impact of public health crises is crucial for patient outcomes.
• Strategies are needed to mitigate the effects of stigma and access barriers on chronic disease management, especially in high-burden settings.